Healthwise, Part 5. Prevention and treatment of type 2 diabetes

2022 ◽  
Vol 16 (1) ◽  
pp. 18-25
Author(s):  
Linda Nazarko
Keyword(s):  
Public Health ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Hospital Treatment ◽  
Death Rates ◽  
Prevention And Treatment ◽  
Poor Outcomes ◽  
The Uk

The coronavirus (COVID-19) pandemic has highlighted the importance of public health in the UK and globally. The UK's death rates and obesity rates are related and many people in the UK experience poor health because they are overweight or obese ( Lobstein, 2021 ; Mohammad et al, 2021 ). Obesity increases the risks of developing type 2 diabetes. People with both type 1 and type 2 diabetes are at greater risk of developing severe COVID symptoms, of requiring hospital treatment and of poor outcomes and death ( Barron et al, 2020 ). This article, the fifth in a series, examines risk factors for type 2 diabetes and explains how readers can reduce their risk of developing type 2 diabetes.

scholarly journals Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factors

2021 ◽  
Author(s):  
Carina Kirstine Klarskov ◽  
Elena von Rohden ◽  
Birger Thorsteinsson ◽  
Lise Tarnow ◽  
Peter Lommer Kristensen
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Gustatory Sweating

Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK

2015 ◽  
Vol 32 (9) ◽  
pp. 1119-1120 ◽  
Author(s):  
N. Holman ◽  
B. Young ◽  
R. Gadsby
Keyword(s):  
Type 2 Diabetes ◽  
Current Prevalence ◽  
Adults And Children ◽  
The Uk

The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes

2009 ◽  
Vol 88 (10) ◽  
pp. 1153-1157 ◽  
Author(s):  
Melanie E. Inkster ◽  
Tom P. Fahey ◽  
Peter T. Donnan ◽  
Graham P. Leese ◽  
Gary J. Mires ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Fetal Outcomes ◽  
Pregnancy Risk

Prevalence and risk factors of fatigue in type 1 and type 2 diabetes: A systematic review and meta‐analysis

2021 ◽  
Author(s):  
Debby Syahru Romadlon ◽  
Faizul Hasan ◽  
Bayu Satria Wiratama ◽  
Hsiao‐Yean Chiu
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis

The world pandemic of diabetes

2011 ◽  
pp. 1795-1799
Author(s):  
Nigel Unwin
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 1 Diabetes ◽  
Geographical Area ◽  
Age Groups ◽  
The World ◽  
Level Of Economic Development ◽  
Increasing Trends

A pandemic refers to a disease that is rapidly increasing in frequency across many populations, over a wide geographical area (1). Put another way, it refers to the situation in which epidemics of the disease are occurring simultaneously in many countries. This is the case for diabetes, which has the dubious distinction of being one of the few chronic non-communicable diseases known to be increasing in all countries from which data are available, irrespective of the level of economic development (2). This is mirrored by a pandemic of people who are overweight or obese (3), the major risk factors for type 2 diabetes. This chapter focuses on diabetes in adults (aged 20 years old and above), of which 85% to more than 95%, depending on the population, have type 2 diabetes (2, 4), which is thus the main contributor to the growing burden of diabetes. However, it is worth noting that, in children (<15 years old), the incidence of type 1 diabetes is also increasing, particularly in the youngest age groups, across the vast majority of countries from which good data are available (5). The reasons for this increase are unclear, although various environmental risk factors have been implicated (5). This chapter aims to do the following: ◆ provide an overview of the prevalence and trends in diabetes in adults across the world and its contribution to mortality ◆ describe the broad determinants that underlie the increasing trends in diabetes in adults ◆ provide an introduction to variations by ethnicity in the prevalence of type 2 diabetes

scholarly journals Differences in Risk Factors for Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland

Medicina ◽  
2020 ◽  
Vol 56 (4) ◽  
pp. 177
Author(s):  
Wojciech Matuszewski ◽  
Magdalena M. Stefanowicz-Rutkowska ◽  
Magdalena Szychlińska ◽  
Elżbieta Bandurska-Stankiewicz
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Retinopathy ◽  
Kidney Disease ◽  
Study Group

Background and Objective: Nowadays, diabetes is one of the main causes of blindness in the world. Identification and differentiation of risk factors for diabetic retinopathy depending on the type of diabetes gives us the opportunity to fight and prevent this complication. Aim of the research: To assess differences in the risk factors for diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in Warmia and Mazury Region, Poland. Materials and Methods: Risk factors for diabetic retinopathy (DR) were assessed on the basis of an original questionnaire, which included: personal data, clinical history of diabetes and eye disease. Elements of clinical examination: blood pressure, BMI, waist circumference. Indicators of diabetes metabolic control: mean glycemia, glycated hemoglobin (HbA1c), total cholesterol and triglycerides, creatinine, glomerular filtration rate (GFR), albumin–creatinine ratio in urine. Results: The study group included 315 (26%) patients with DM1 and 894 (74%) patients with DM2. Risk factors were estimated on the basis of logistic regression and verified with Student’s t-test. Statistically significant dependencies were found in both groups between the occurrence of diabetic retinopathy and diabetes duration, HbA1c, triglyceride concentrations, indicators of kidney function and cigarette smoking status. In the DM2 group, the development of DR was significantly influenced by the implemented models of diabetic treatment. Conclusions: In the whole study group, the risk of DR was associated with the duration of diabetes, HbA1c, triglyceride concentrations and smoking. In DM1 patients, the risk of DR was associated with diabetic kidney disease in the G1A1/A2 stage of chronic kidney disease, and in DM2 patients with the G2 stage of chronic kidney disease. An important risk factor for DR in DM2 patients was associated with late introduction of insulin therapy.

Sign in / Sign up

Export Citation Format

Share Document